Andrew Whiting,Carrie Ambler,Mark Coles,David Chisholm
申请号:
US16323924
公开号:
US20190209684A1
申请日:
2017.08.09
申请国别(地区):
US
年份:
2019
代理人:
摘要:
There are described novel compounds of formula I: (I) in which, in which A1, A2, A3, A4, R1 and R2 are each as herein defined, for use in the treatment or alleviation of an RAR mediated condition; and methods related thereto.